With the development of nanotechnology, nanomedicines are widely used in tumor therapy.
However, biological barriers in the delivery of nanoparticles still limit their application in …

As immunogenic cell death (ICD) inducers initiating antitumor immune responses, certain
chemotherapeutic drugs have shown considerable potential to reverse the …

The limitations of conventional cancer treatment are driving the emergence and
development of nanomedicines. Research in liposomal nanomedicine for cancer therapy is …

Cancer photothermal (PTT) and photodynamic therapies (PDT) have aroused tremendous
attention with high spatial specificity, but they experience the challenges from the inefficient …

Recent advancements in RNA therapeutics highlight the critical need for precision gene
delivery systems that target specific organs and cells. Lipid nanoparticles (LNPs) have …

Ever since the development of the first vaccine, vaccination has had the great impact on
global health, leading to the decrease in the burden of numerous infectious diseases …

Oxidation modulators regarding antioxidants and reactive oxygen species (ROS) inducers
have been used for the treatment of many diseases. However, a systematic review that …

Cancer presents a formidable threat to human health, with the majority of cases currently
lacking a complete cure. Frequently, chemotherapy drugs are required to impede its …

While spray-drying has been widely utilized to improve the bioavailability of poorly water-
soluble drugs, the outcomes often exhibit suboptimal particle size distribution and large …

Delivering drugs selectively to tumor tissues is a significant challenge in cancer therapy, and
pH-responsive polymeric assemblies have shown great potential in achieving this goal. In …